ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
SHBG: biomarker and hepatokine?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 201858" data-attributes="member: 13851"><p><strong>Highlights</strong></p><p></p><p><em><strong>A recent genome-wide association study has identified a cluster of de novo lipogenesis genes that affect serum sex hormone-binding globulin (SHBG) levels. </strong></em></p><p><em><strong></strong></em></p><p><em><strong>A recent Mendelian randomization study has shown that SHBG functions as a true hepatokine, at least in women, by reducing the risk of type 2 diabetes. </strong></em></p><p><em><strong></strong></em></p><p><strong><em>-raising therapies, such as inhibitors of de novo lipogenesis or thyroid hormone receptor beta-agonists, may provide promising future directions for the treatment and prevention of type 2 diabetes and polycystic ovary syndrome</em></strong></p></blockquote><p></p>
[QUOTE="madman, post: 201858, member: 13851"] [B]Highlights[/B] [I][B]A recent genome-wide association study has identified a cluster of de novo lipogenesis genes that affect serum sex hormone-binding globulin (SHBG) levels. A recent Mendelian randomization study has shown that SHBG functions as a true hepatokine, at least in women, by reducing the risk of type 2 diabetes. [/B][/I] [B][I]-raising therapies, such as inhibitors of de novo lipogenesis or thyroid hormone receptor beta-agonists, may provide promising future directions for the treatment and prevention of type 2 diabetes and polycystic ovary syndrome[/I][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
SHBG: biomarker and hepatokine?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top